CBIO

Crescent Biopharma, Inc. Common Stock
CBIO

Overview Fund Activity

36 hedge funds and large institutions have $3M invested in Crescent Biopharma, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 10 closing their positions.

Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
4
Reduced
12
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Two Sigma Advisers
1
Two Sigma Advisers
New York
$42.1K
2
HWA
2
HCR Wealth Advisors
California
$16.9K
3
GCP
3
GSA Capital Partners
United Kingdom
$14K
4
Two Sigma Investments
4
Two Sigma Investments
New York
$7.55K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$88.1K

Top Sellers

1
AG
1
Artal Group
Luxembourg
$0
2
Goldman Sachs
2
Goldman Sachs
New York
$0
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$59K
4
Millennium Management
4
Millennium Management
New York
$3.19K
5
SIG
5
Sargent Investment Group
Maryland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
51
Simplex Trading
Illinois
– – – –
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
– – – –
1 2
3